Eton Pharmaceuticals Inc (ETON)

Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	54.90%37.59	24.27	21.28	22.46	18.93
Cost Of Revenue	27.75%12.18	9.53	8.18	14.60	7.00
Gross Profit	72.47%25.41	14.74	13.10	7.86	11.92
	2.42%12.62	12.32	10.64	9.22	13.40
Research and Development	47.04%0.99	1.88	1.78	1.11	3.71
Interest Income/Expense	10.83%1.01	1.14	-	1.21	1.20
Depreciation and Amortization	22.55%1.39	1.13	1.02	1.01	1.01
Operating Income/Loss	429.99%12.79	2.41	2.46	-1.36	-1.48
Income/Loss From Continuing Operations Before Tax	644.47%11.72	1.57	1.41	-1.96	-2.52
Income Tax Expense/Benefit	600.00%0.14	0.02	-0.07	-0.03	0.07
	645.05%11.58	1.55	1.48	-1.93	-2.59
Attributable To Parent	645.05%11.58	1.55	1.48	-1.93	-2.59
Basic Average Shares	1.31%27.64	27.29	-	26.89	26.89
Diluted Average Shares	3.93%32.79	31.55	-	26.89	-
Basic Earnings Per Share	600.00%0.42	0.06	-	-0.07	-0.10
Diluted Earnings Per Share	600.00%0.35	0.05	-	-0.07	-